References
- Abritis, A., A. Marcus, and I. Oransky. 2020. “An ‘Alarming’ and ‘Exceptionally High’ Rate of COVID-19 Retractions?” Accountability in Research 1–2. doi:https://doi.org/10.1080/08989621.2020.1793675.
- Agiesta, J. 2020. “CNN Poll: Most Americans Would Be Uncomfortable Returning to Regular Routines Today.” CNN. Accessed 11 July 2020. https://www.cnn.com/2020/05/12/politics/cnn-poll-americans-uncomfortable-routines/index.html
- Barnett, A. G., and D. Moher. 2019. “Turning the Tables: A University League-Table Based on Quality Not Quantity [Version 1; Peer Review: 1 Approved].” F1000Research 8: 583. doi:https://doi.org/10.12688/f1000research.18453.1.
- Begley, C. G., and L. M. Ellis. 2012. “Drug Development: Raise Standards for Preclinical Cancer Research.” Nature 483 (7391): 531–533. doi:https://doi.org/10.1038/483531a.
- Benedictus, R., F. Miedema, and M. W. Ferguson. 2016. “Fewer Numbers, Better Science.” Nature 538 (7626): 453–455. doi:https://doi.org/10.1038/538453a.
- Cicerone, R. J. 2010. “Ensuring Integrity in Science.” Science 327 (5966): 624. doi:https://doi.org/10.1126/science.1187612.
- Collins, F. S., and L. A. Tabak. 2014. “Policy: NIH Plans to Enhance Reproducibility.” Nature 505 (7485): 612–613. doi:https://doi.org/10.1038/505612a.
- Crossley, N. A., E. Sena, J. Goehler, J. Horn, B. van der Worp, P. M. Bath, M. Macleod, and U. Dirnagl. 2008. “Empirical Evidence of Bias in the Design of Experimental Stroke Studies: A Metaepidemiologic Approach.” Stroke 39 (3): 929–934. doi:https://doi.org/10.1161/STROKEAHA.107.498725.
- Deutsche Forschungsgemeinschaft. 2019. “Recommendations for the Promotion of Translational Research in University Medicine.” https://www.dfg.de/download/pdf/dfg_im_profil/reden_stellungnahmen/2019/190919_stellungnahme_empfehlung_ag_translation.pdf
- Dirnagl, U. 2020. “Preregistration of Exploratory Research: Learning from the Golden Age of Discovery.” PLoS Biology 18 (3): e3000690. doi:https://doi.org/10.1371/journal.pbio.3000690.
- Egan, K. J., H. M. Vesterinen, V. Beglopoulos, E. S. Sena, and M. R. Macleod. 2016. “From a Mouse: Systematic Analysis Reveals Limitations of Experiments Testing Interventions in Alzheimer’s Disease Mouse Models.” Evidence-Based Preclinical Medicine 3 (1): e00015. doi:https://doi.org/10.1002/ebm2.15.
- Enserink, M. 2017. “Sloppy Reporting on Animal Studies Proves Hard to Change.” Science 357 (6358): 1337–1338. doi:https://doi.org/10.1126/science.357.6358.1337.
- Garner, J. P., B. N. Gaskill, E. M. Weber, J. Ahloy-Dallaire, and K. R. Pritchett-Corning. 2017. “Introducing Therioepistemology: The Study of How Knowledge Is Gained from Animal Research.” Lab Animal 46 (4): 103–113. doi:https://doi.org/10.1038/laban.1224.
- Goldacre, B., N. J. DeVito, C. Heneghan, F. Irving, S. Bacon, J. Fleminger, and H. Curtis. 2018. “Compliance with Requirement to Report Results on the EU Clinical Trials Register: Cohort Study and Web Resource.” BMJ 362 (September): k3218. doi:https://doi.org/10.1136/bmj.k3218.
- Hakala, A. K., D. Fergusson, and J. Kimmelman. 2017. “Nonpublication of Trial Results for New Neurological Drugs: A Systematic Review.” Annals of Neurology 81 (6): 782–789. doi:https://doi.org/10.1002/ana.24952.
- Hardin, R. Trust and Trustworthiness. Russell Sage Foundation, 2002, New York, New York.
- Hartung, T. 2013. “Food for Thought Look Back in Anger – What Clinical Studies Tell Us about Preclinical Work.” ALTEX 30 (3): 275–291. doi:https://doi.org/10.14573/altex.2013.3.275.
- Hilal, T., M. Gonzalez-Velez, and V. Prasad. 2020. “Limitations in Clinical Trials Leading to Anticancer Drug Approvals by the US Food and Drug Administration.” JAMA Internal Medicine 180 (8, June): 1108. doi:https://doi.org/10.1001/jamainternmed.2020.2250.
- Hirst, J. A., J. Howick, J. K. Aronson, N. Roberts, R. Perera, C. Koshiaris, and C. Heneghan. 2014. “The Need for Randomization in Animal Trials: An Overview of Systematic Reviews.” PLoS One 9 (6): e98856. doi:https://doi.org/10.1371/journal.pone.0098856.
- Howells, D. W., E. S. Sena, and M. R. Macleod. 2014. “Bringing Rigour to Translational Medicine.” Nature Reviews. Neurology 10 (1): 37–43. doi:https://doi.org/10.1038/nrneurol.2013.232.
- Institute of Medicine. 2013. Sharing Clinical Research Data: WorkshopSummary. Washington, DC: National Academies Press (US); 2013 Mar 29. 9780309268745 0309268745.
- Ioannidis, J. P. A. 2017. “Acknowledging and Overcoming Nonreproducibility in Basic and Preclinical Research.” JAMA 317 (10): 1019–1020. doi:https://doi.org/10.1001/jama.2017.0549.
- Jefferson, T., and L. Jorgensen. 2018. “Redefining the ‘E’ in EBM.” BMJ Evidence-Based Medicine 23 (2): 46–47. doi:https://doi.org/10.1136/bmjebm-2018-110918.
- Joseph, A. 2020. “Lancet, NEJM Retract Covid-19 Studies That Sparked Backlash.” STAT (blog), June 4. https://www.statnews.com/2020/06/04/lancet-retracts-major-covid-19-paper-that-raised-safety-concerns-about-malaria-drugs/
- Kilkenny, C., W. J. Browne, I. C. Cuthill, M. Emerson, and D. G. Altman. 2010. “Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research.” PLoS Biology 8 (6): e1000412. doi:https://doi.org/10.1371/journal.pbio.1000412.
- Kimmelman, J., and A. J. London. 2015. “The Structure of Clinical Translation: Efficiency, Information, and Ethics.” The Hastings Center Report 45 (2): 27–39. doi:https://doi.org/10.1002/hast.433.
- Kimmelman, J., J. S. Mogil, and U. Dirnagl. 2014. “Distinguishing between Exploratory and Confirmatory Preclinical Research Will Improve Translation.” PLoS Biology 12 (5): e1001863. doi:https://doi.org/10.1371/journal.pbio.1001863.
- Lindner, M. D. 2007. “Clinical Attrition Due to Biased Preclinical Assessments of Potential Efficacy.” Pharmacology & Therapeutics 115 (1): 148–175. doi:https://doi.org/10.1016/j.pharmthera.2007.05.002.
- Lund, H., K. Brunnhuber, C. Juhl, K. Robinson, M. Leenaars, B. F. Dorch, G. Jamtvedt, M. W. Nortvedt, R. Christensen, and I. Chalmers. 2016. “Towards Evidence Based Research.” BMJ 355 (October): i5440. doi:https://doi.org/10.1136/bmj.i5440.
- Macleod, M. R., A. L. McLean, A. Kyriakopoulou, S. Serghiou, A. de Wilde, N. Sherratt, T. Hirst, R. Hemblade, Z. Bahor, C. Nunes-Fonseca, et al. 2015. “Risk of Bias in Reports of in Vivo Research: A Focus for Improvement.” PLoS Biology 13 (10): e1002273. doi:https://doi.org/10.1371/journal.pbio.1002273.
- Matthews, D. 2020. “French Trust in Science Drops as Coronavirus Backlash Begins.” Times Higher Education (THE), June 8. https://www.timeshighereducation.com/news/french-trust-science-drops-coronavirus-backlash-begins
- Mejlgaard, N., L. M. Bouter, G. Gaskell, P. Kavouras, N. Allum, A.-K. Bendtsen, C. A. Charitidis, N. Claesen, K. Dierickx, A. Domaradzka, et al. 2020. “Research Integrity: Nine Ways to Move from Talk to Walk.” Nature 586 (7829): 358–360. doi:https://doi.org/10.1038/d41586-020-02847-8.
- Minnerup, J., U. Dirnagl, and W. R. Schabitz. 2020. “Checklists for Authors Improve the Reporting of Basic Science Research.” Stroke 51 (1): 6–7. doi:https://doi.org/10.1161/STROKEAHA.119.027626.
- Moher, D., P. Glasziou, I. Chalmers, M. Nasser, P. M. Bossuyt, D. A. Korevaar, I. D. Graham, P. Ravaud, and I. Boutron. 2016. “Increasing Value and Reducing Waste in Biomedical Research: Who’s Listening?” Lancet 387 (10027): 1573–1586. doi:https://doi.org/10.1016/S0140-6736(15)00307-4.
- Nature. 2010. “A Question of Trust.” Nature 466 (7302): 7. doi:https://doi.org/10.1038/466007a.
- Nosek, B. A., C. R. Ebersole, A. C. DeHaven, and D. T. Mellor. 2018. “The Preregistration Revolution.” Proceedings of the National Academy of Sciences 115 (11): 2600. doi:https://doi.org/10.1073/pnas.1708274114.
- O’Connor, A. M., and J. M. Sargeant. 2014. “Critical Appraisal of Studies Using Laboratory Animal Models.” ILAR Journal 55 (3): 405–417. doi:https://doi.org/10.1093/ilar/ilu038.
- Peers, I. S., M. C. South, P. R. Ceuppens, J. D. Bright, and E. Pilling. 2014. “Can You Trust Your Animal Study Data?” Nature Reviews. Drug Discovery 13 (7): 560. doi:https://doi.org/10.1038/nrd4090-c1.
- Perrin, S. 2014. “Preclinical Research: Make Mouse Studies Work.” Nature News 507 (7493): 423. doi:https://doi.org/10.1038/507423a.
- Reichlin, T. S., L. Vogt, and H. Würbel. 2016. “The Researchers’ View of Scientific Rigor—Survey on the Conduct and Reporting of in Vivo Research.” PLoS One 11 (12): e0165999. doi:https://doi.org/10.1371/journal.pone.0165999.
- “Reporting Standards and Availability of Data, Materials, Code and Protocols.” n.d. https://www.nature.com/nature-research/editorial-policies/reporting-standards
- Riveros, C., A. Dechartres, E. Perrodeau, R. Haneef, I. Boutron, and P. Ravaud. 2013. “Timing and Completeness of Trial Results Posted at ClinicalTrials.Gov and Published in Journals.” PLoS Medicine 10 (12): e1001566; discussion e1001566. doi:https://doi.org/10.1371/journal.pmed.1001566.
- Robinson, K. A., and S. N. Goodman. 2011. “A Systematic Examination of the Citation of Prior Research in Reports of Randomized, Controlled Trials.” Annals of Internal Medicine 154 (1): 50–55. doi:https://doi.org/10.7326/0003-4819-154-1-201101040-00007.
- Schmidt-Pogoda, A., N. Bonberg, M. H. M. Koecke, J. K. Strecker, J. Wellmann, N. M. Bruckmann, C. Beuker, W-R. Schabitz, S. Meuth, H. Wiendl, H. Minnerup, J. Minnerup. 2019. “Why Most Acute Stroke Studies are Positive in Animals but Not in Patients.” Annals of Neurology, November. doi:https://doi.org/10.1002/ana.25643.
- Sena, E. S., H. B. van der Worp, P. M. Bath, D. W. Howells, and M. R. Macleod. 2010. “Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy.” PLoS Biology 8 (3): e1000344. doi:https://doi.org/10.1371/journal.pbio.1000344.
- Sert, N. P. D., A. Ahluwalia, S. Alam, M. T. Avey, M. Baker, W. J. Browne, A. Clark, et al. 2020. “Reporting Animal Research: Explanation and Elaboration for the ARRIVE Guidelines 2.0.” PLoS Biology 18 (7): e3000411. doi:https://doi.org/10.1371/journal.pbio.3000411.
- Smith, R. 2014. “Richard Smith: Why Scientists Should Be Held to a Higher Standard of Honesty than the Average Person.” The BMJ. September, https://blogs.bmj.com/bmj/2014/09/02/richard-smith-why-scientists-should-be-held-to-a-higher-standard-of-honesty-than-the-average-person/.
- Strand, L. B., P. Clarke, N. Graves, and A. G. Barnett. 2017. “Time to Publication for Publicly Funded Clinical Trials in Australia: An Observational Study.” BMJ Open 7 (3): e012212. doi:https://doi.org/10.1136/bmjopen-2016-012212.
- Tsilidis, K. K., O. A. Panagiotou, E. S. Sena, E. Aretouli, E. Evangelou, D. W. Howells, R. A.-S. Salman, M. R. Macleod, and J. P. A. Ioannidis. 2013. “Evaluation of Excess Significance Bias in Animal Studies of Neurological Diseases.” Edited by Lisa Bero. PLoS Biology 11 (7): e1001609. doi:https://doi.org/10.1371/journal.pbio.1001609.
- Vogt, L., T. S. Reichlin, C. Nathues, and W. Hanno. 2016. “Authorization of Animal Experiments Is Based on Confidence Rather than Evidence of Scientific Rigor.” PLoS Biology 14 (12): 12. doi:https://doi.org/10.1371/journal.pbio.2000598.
- Wadman, M. 2010.“NIH to Tighten Rules on Conflicts.” Nature, May. doi:https://doi.org/10.1038/news.2010.257.
- Ware, J. J., and M. R. Munafo. 2014.“Significance Chasing in Research Practice: Causes, Consequences and Possible Solutions.” Addiction, July. doi:https://doi.org/10.1111/add.12673.
- Wieschowski, S., W. W. L. Chin, C. Federico, S. Sievers, J. Kimmelman, and D. Strech. 2018. “Preclinical Efficacy Studies in Investigator Brochures: Do They Enable Risk-Benefit Assessment?” PLOS Biology 16 (4): e2004879. doi:https://doi.org/10.1371/journal.pbio.2004879.
- Willmann, R., J. Lee, C. Turner, K. Nagaraju, A. Aartsma-Rus, D. J. Wells, K. R. Wagner, et al. 2020. “Improving Translatability of Preclinical Studies for Neuromuscular Disorders: Lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT).” Disease Models & Mechanisms 13 (2): dmm042903. doi:https://doi.org/10.1242/dmm.042903.
- Yarborough, M. 2014a. “Taking Steps to Increase the Trustworthiness of Scientific Research.” The FASEB Journal 28 (9): 3841–3846. doi:https://doi.org/10.1096/fj.13-246603.
- Yarborough, M. 2014b. “Openness in Science Is Key to Keeping Public Trust.” Nature News 515 (7527): 313. doi:https://doi.org/10.1038/515313a.
- Yarborough, M. 2020a. “Rescuing Informed Consent: How the New ‘Key Information’ and ‘Reasonable Person’ Provisions in the Revised U.S. Common Rule Open the Door to Long Overdue Informed Consent Disclosure Improvements and Why We Need to Walk through that Door.” Science and Engineering Ethics 26 (3): 1423–1443. doi:https://doi.org/10.1007/s11948-019-00170-8.
- Yarborough, M. 2020b. “Do We Really Know How Many Clinical Trials are Conducted Ethically? Why Research Ethics Committee Review Practices Need to Be Strengthened and Initial Steps We Could Take to Strengthen Them.” Journal of Medical Ethics, June: medethics-2019-106014. doi:https://doi.org/10.1136/medethics-2019-106014.
- Yarborough, M., A. Bredenoord, F. D’Abramo, N. C. Joyce, J. Kimmelman, U. Ogbogu, E. Sena, D. Strech, and U. Dirnagl. 2018. “The Bench Is Closer to the Bedside than We Think: Uncovering the Ethical Ties between Preclinical Researchers in Translational Neuroscience and Patients in Clinical Trials.” PLOS Biology 16 (6): e2006343. doi:https://doi.org/10.1371/journal.pbio.2006343.
- Yarborough, M., R. Nadon, and D. G. Karlin. 2019. “Four Erroneous Beliefs Thwarting More Trustworthy Research.” ELife 8 (July): e45261. doi:https://doi.org/10.7554/eLife.45261.
- Zarin, D. A., S. N. Goodman, and J. Kimmelman. 2019. “Harms From Uninformative Clinical Trials.” JAMA 322 (9): 813–814. doi:https://doi.org/10.1001/jama.2019.9892.